Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Rubius Therapeutics Inc (NQ: RUBY )

9.320 UNCHANGED
Streaming Delayed Price Updated: 8:01 AM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Rubius Therapeutics Inc

< Previous 1 2 3 4 Next >
72 Biggest Movers From Friday
Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares climbed 48% to close at $5.58 on Friday. Lixte Biotech recently ... 
Tags EDSA METX GTT
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock rose 49.25% to $5.63 during Friday's regular session. Trading ... 
Tags Top Gainers AMTI Markets
From Benzinga
48 Stocks Moving In Friday's Mid-Day Session
Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares jumped 52.8% to $5.76. Lixte Biotech recently said it will ... 
Tags ENV SSNT Top Gainers
From Benzinga
First Week of RUBY April 16th Options Trading
Investors in Rubius Therapeutics Inc (RUBY) saw new options become available this week, for the April 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RUBY... 
Tags Stocks
From Market News Video
70 Biggest Movers From Yesterday
Gainers Pandion Therapeutics, Inc. (NASDAQ: PAND) shares surged 133.4% to close at $59.81 on Thursday after the company announced ... 
Tags CDXC Benzinga SCR
From Benzinga
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags VLON General MDT
From Benzinga
Earnings Scheduled For February 23, 2021
Companies Reporting Before The Bell • MFA Finl (NYSE:MFA) is likely to report quarterly earnings at $0.07 per share on ... 
Tags Pre/Market Outlook ECC MFA
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags Small Cap ALBO FDA
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Penny Stocks VIRI VINC
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
On Thursday morning, 92 companies achieved new highs for the year. Interesting Highlights: Abbott ... 
Tags NICK Trading Ideas Intraday Update
From Benzinga
The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FUSN EW LGND
From Benzinga
98 Biggest Movers From Yesterday
Gainers Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) shares jumped 537.5% to close at $25.50 on Wednesday after the company priced ... 
Tags Markets RIG KBSF
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Sorrento Therapeutics (NASDAQ:SRNE) stock increased by 33.3% to $13.89 during Wednesday's regular session. ... 
Tags Top Gainers Intraday Update Markets
From Benzinga
RUBY Crosses Above Average Analyst Target
In recent trading, shares of Rubius Therapeutics Inc (RUBY) have crossed above the average analyst 12-month target price of $9.33, changing hands for $9.53/share. When a stock reaches the target an... 
Tags ETFs
From ETF Channel
68 Biggest Movers From Yesterday
Gainers Prevail Therapeutics Inc. (NASDAQ: PRVL) shares jumped 82% to close at $22.75 on Tuesday after the company agreed to be ... 
Tags HJLI SOL ARVN
From Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
Gainers Prevail Therapeutics Inc. (NASDAQ: PRVL) shares climbed 83.5% to $22.93 after the company agreed to be acquired by Eli ... 
Tags OCX SLDB Trading Ideas
From Benzinga
70 Biggest Movers From Yesterday
Gainers Arvinas, Inc. (NASDAQ: ARVN) shares climbed 95.1% to close at $58.38 on Monday after the company reported ... 
Tags APLS BLRX VNCE
From Benzinga
12 Healthcare Stocks Moving In Monday's After-Market Session
Gainers Opiant Pharmaceuticals (NASDAQ:OPNT) stock increased by 38.38% to $11.5 during Monday's after-market session. Opiant ... 
Tags SLDB Market News KZR
From Benzinga
Noteworthy Monday Option Activity: RUBY, LGND, FIXX
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Rubius Therapeutics Inc (RUBY), where a total volume of 9,633 contracts has been... 
Tags Stocks
From Market News Video
12 Healthcare Stocks Moving In Monday's Intraday Session
Gainers Arvinas (NASDAQ:ARVN) shares rose 88.77% to $56.5 during Monday's regular session. The current volume of ... 
Tags Top Gainers BCDA TLGT
From Benzinga
52 Stocks Moving In Monday's Mid-Day Session
Gainers Arvinas, Inc. (NASDAQ: ARVN) shares jumped 103.4% to $60.87 after the company reported interim clinical data for its ... 
Tags XXII SYBX ALGS
From Benzinga
72 Biggest Movers From Friday
Gainers AbCellera Biologics Inc. (NASDAQ: ABCL) shares jumped 194.5% to close at $58.90 after the company priced its IPO at $20 ... 
Tags IPHA ALXO AYTU
From Benzinga
Rubius Therapeutics Breaks Above 200-Day Moving Average - Bullish for RUBY
In trading on Monday, shares of Rubius Therapeutics Inc (RUBY) crossed above their 200 day moving average of $5.66, changing hands as high as $5.83 per share. Rubius Therapeutics Inc shares are... 
Tags Stocks
From Market News Video
Implied VBK Analyst Target Price: $260
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags CSTL OPNT NAVB
From Benzinga
Earnings Scheduled For August 10, 2020
Companies Reporting Before The Bell • Acacia Research Inc. (NASDAQ:ACTG) is expected to report quarterly loss at $0.02 per share ... 
Tags SPG SCOR TME
From Benzinga
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions, And Smid-Cap Earnings
Biotech stocks advanced in the week ended August 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus treatment/vaccine news flow... 
Tags Stocks / Equities Healthcare Pharma/Biotech
From Blogs - TalkMarkets
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive ... 
Tags IART OCGN ALT
From Benzinga
Analysts Expect VB Will Reach $167
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Relative Strength Alert For Rubius Therapeutics
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.